Cargando…
Comparative Pharmacokinetics of Seven Major Compounds in Normal and Atherosclerosis Mice after Oral Administration of Simiao Yong'an Decoction
Simiao Yong'an decoction (SMYAD), a classic traditional Chinese medicine formula, has been used to treat atherosclerosis (AS) in clinical in China, but its therapeutic mechanism and pharmacodynamic material basis are not clear. In this study, the AS model was caused by a high-fat diet and periv...
Autores principales: | Sun, Ke-han, Yang, Man-fang, Xu, Xin-rui, Li, Yang, Gao, Zhao, Zhang, Qing-yue, Li, Hui, Wang, Shu-qi, Lou, Li-xia, Wu, Ai-ming, Jin, Qiu-shuo, Wu, Sheng-xian, Nie, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071858/ https://www.ncbi.nlm.nih.gov/pubmed/35529931 http://dx.doi.org/10.1155/2022/4604601 |
Ejemplares similares
-
Exploration of Simiao-Yongan Decoction on knee osteoarthritis based on network pharmacology and molecular docking
por: Wang, Ying, et al.
Publicado: (2023) -
Simultaneous Determination of Seven Components in Rat Plasma by the UPLC-MS/MS Method and Application of Pharmacokinetic Studies to SimiaoYong’an Decoction
por: Liu, Yuanyan, et al.
Publicado: (2017) -
Topical use of Jiawei Simiao Yongan Gao to prevent radiodermatitis in patients with head and neck cancer: A retrospective cohort study
por: Song, Fengli, et al.
Publicado: (2020) -
Mechanism of Simiao Decoction in the treatment of atherosclerosis based on network pharmacology prediction and molecular docking
por: Li, Qian, et al.
Publicado: (2023) -
Si-Miao-Yong-An (SMYA) Decoction May Protect the Renal Function Through Regulating the Autophagy-Mediated Degradation of Ubiquitinated Protein in an Atherosclerosis Model
por: Zhu, Ze-Bing, et al.
Publicado: (2020)